...
首页> 外文期刊>Nature >Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death
【24h】

Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death

机译:外在的组蛋白H4通过诱导溶解性细胞死亡来协调慢性炎症

获取原文
获取原文并翻译 | 示例

摘要

The perpetuation of inflammation is an important pathophysiological contributor to the global medical burden. Chronic inflammation is promoted by non-programmed cell death(1,)(2); however, how inflammation is instigated, its cellular and molecular mediators, and its therapeutic value are poorly defined. Here we use mouse models of atherosclerosis-a major underlying cause of mortality worldwide-to demonstrate that extracellular histone H4-mediated membrane lysis of smooth muscle cells (SMCs) triggers arterial tissue damage and inflammation. We show that activated lesional SMCs attract neutrophils, triggering the ejection of neutrophil extracellular traps that contain nuclear proteins. Among them, histone H4 binds to and lyses SMCs, leading to the destabilization of plaques; conversely, the neutralization of histone H4 prevents cell death of SMCs and stabilizes atherosclerotic lesions. Our data identify a form of cell death found at the core of chronic vascular disease that is instigated by leukocytes and can be targeted therapeutically.
机译:炎症的持续是全球医疗负担的重要病理生理因素。非程序性细胞死亡会促进慢性炎症(1,)(2);然而,如何激发炎症,其细胞和分子介质以及其治疗价值尚不清楚。在这里,我们使用动脉粥样硬化的小鼠模型(动脉粥样硬化是世界范围内导致死亡的主要潜在原因)来证明细胞外组蛋白H4介导的平滑肌细胞(SMC)的膜裂解引发动脉组织损伤和炎症。我们表明激活的病变SMCs吸引中性粒细胞,触发包含核蛋白的中性粒细胞外陷阱的弹出。其中,组蛋白H4与SMC结合并溶解,导致斑块不稳定。相反,组蛋白H4的中和可防止SMCs的细胞死亡并稳定动脉粥样硬化病变。我们的数据确定了一种在白细胞刺激下的慢性血管疾病核心中发现的细胞死亡形式,可以作为治疗靶点。

著录项

  • 来源
    《Nature 》 |2019年第7755期| 236-240| 共5页
  • 作者单位

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|AMC, Dept Pathol, Amsterdam, Netherlands|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|AMC, Dept Pathol, Amsterdam, Netherlands|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany;

    Univ Maastricht, Dept Biochem, CARIM, Maastricht, Netherlands;

    Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;

    Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France;

    Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Dev & Cell Biol, Madrid, Spain;

    Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;

    Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    LMU Munchen, Med Klin & Poliklin 4, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    AMC, Dept Pathol, Amsterdam, Netherlands;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|AMC, Dept Pathol, Amsterdam, Netherlands;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany;

    LMU Munchen, BMC, Metab Biochem, Munich, Germany;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|Univ Maastricht, Dept Biomed Engn, CARIM, Maastricht, Netherlands;

    Scripps Res Inst, La Jolla, CA 92037 USA;

    Univ Hosp Essen, Inst Expt Immunol & Imaging, Essen, Germany;

    German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany|Tech Univ Munich, Dept Vasc & Endovasc Surg, Munich, Germany|Karolinska Inst, Dept Med Solna, Stockholm, Sweden;

    Univ Maastricht, Dept Biochem, CARIM, Maastricht, Netherlands;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|AMC, Dept Med Biochem, Amsterdam, Netherlands;

    AMC, Dept Pathol, Amsterdam, Netherlands;

    Max Planck Inst Biochem, Martinsried, Germany;

    LMU Munchen, Med Klin & Poliklin 4, Munich, Germany;

    Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany;

    Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany|Univ Maastricht, Dept Biochem, CARIM, Maastricht, Netherlands;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Dev & Cell Biol, Madrid, Spain;

    Univ Maastricht, Dept Biochem, CARIM, Maastricht, Netherlands;

    Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;

    LMU Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany|AMC, Dept Pathol, Amsterdam, Netherlands|German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany|Karolinska Inst, Dept Med Solna, Stockholm, Sweden|Karolinska Inst, Dept Physiol & Pharmacol FyFa, Stockholm, Sweden;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号